Biosplice Therapeutics, Inc. (“Biosplice”), a clinical-stage biotechnology company pioneering advancements in small molecule inhibition of CDC-like kinases (CLK) and Dual-specificity tyrosine ...

An artificial intelligence (AI)-based model accurately classified pediatric sarcomas using digital pathology images alone, ...

Plasma-activated medium (PAM) shows tumor-fighting effects against the rare form of cancer known as synovial sarcoma, an ...

The following is a summary of "Impact of CT-based adipose tissue distribution and sarcopenia on treatment outcomes in ...

Plasma-activated medium (PAM) shows tumor-fighting effects against the rare form of cancer known as synovial sarcoma, an ...

Not much is known about this difficult disease sarcoma cancer because it is easy to ignore the small lumps in the beginning ...

The 7MM soft tissue sarcoma (STS) market is estimated to reach USD 6,465.7 million by 2030 from USD 2,943.3 million in 2019 at a CAGR of 7.4%.

Annamycin is potentially a highly versatile drug capable of working synergistically with numerous mechanistically different ...

Around 15% of soft tissue sarcomas occur in the arms. People more commonly develop STS in the lower extremities of the body. STS is a rare type of cancer that develops in the soft tissues of the ...

A woman said she was inspired to run her first marathon by her dad's rare cancer diagnosis. Zoë Driver, who lives in Wylye ...